Plain-English translation of NCT07262645 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This study is testing a device called the NirsCure 6000 that uses near-infrared light therapy to see if it can help slow or prevent memory loss in people with mild to moderate Alzheimer's disease. Half of the participants will use the real device, and half will use a sham (fake) device that looks identical but doesn't produce the therapeutic light. Neither you nor the researchers will know which device you're using, which helps ensure the results are fair and unbiased.
There is currently no cure for Alzheimer's disease, and available treatments have limited effectiveness. Researchers are exploring whether near-infrared light therapy might offer a new way to protect brain cells and slow the progression of memory loss in people with this condition.
You likely qualify if…
You likely don't qualify if…
You will use the device at home once daily for 30 minutes, six days per week, for the duration of the study. Your study partner will help you with daily treatment and keep track of how you're doing. You'll have regular visits with the research team to complete memory tests and check-ins, and your study partner will be asked to report on any changes in your thinking, mood, or daily activities. The entire study takes place mostly at home, making it convenient for you and your family.
AI-generated summary from trial data · Jul 13, 2026 · Not medical advice
China